Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
DS gluten free milk chocolate nobbles
0904010A0BHAIBF
|
DS (Gluten free biscuits) | Gluten free/wheat free biscuits | Nutrition and Blood | No data available |
|
DS gluten free pretzels
0904010H0CBAAAA
|
DS (G/F Bread) | Gluten free breads | Nutrition and Blood | No data available |
|
DT/Vac/Ads(Adult) inj 0.5ml pfs
1404000F0AAARAR
|
Diphtheria | Diphtheria | Immunological Products and Vaccines | No data available |
|
DTaP vacc (ads, reduced antigen content) inj 0.5ml inj pfs
1404000F0AABDBD
|
Diphtheria | Diphtheria | Immunological Products and Vaccines | No data available |
|
DTaP vacc (ads) inj 0.5ml pfs
1404000F0AAAVAV
|
Diphtheria | Diphtheria | Immunological Products and Vaccines | No data available |
|
DTaP vacc (ads) inj pfs/Hib conj vacc inj vials
140400060AAADAD
|
Haemophilius influenzae B/diphtheria,tetanus,pertussis | Haemophilus influenzae/diptheria,tetanus,pertussis vaccine | Immunological Products and Vaccines | No data available |
|
dTaP/Hep B (SA)/IP/HbC vaccine (adsorbed) inj 0.5ml pfs
1404000F0AABCBC
|
Diphtheria | Diphtheria | Immunological Products and Vaccines | No data available |
|
dTaP/Hep B (SA)/IP/HbC vaccine (adsorbed) pdr inj 0.5ml pfs
1404000F0AAAZAZ
|
Diphtheria | Diphtheria | Immunological Products and Vaccines | No data available |
|
DTaP/IPV vacc (ads) inj 0.5ml pfs
1404000F0AABBBB
|
Diphtheria | Diphtheria | Immunological Products and Vaccines | No data available |
|
DTaP/IPV/Hib conj vacc (ads) inj 0.5ml vials
1404000F0AABABA
|
Diphtheria | Diphtheria | Immunological Products and Vaccines | No data available |
|
DTIC-Dome 200mg powder for solution for injection vials
0801050L0BBABAB
|
DTIC-Dome | Dacarbazine | Malignant Disease and Immunosuppression | No data available |
|
Dual Action Athlete's Foot 0.12% spray
1310020Y0BGAAAK
|
Boots Dual Action Athlete's Foot | Tolnaftate | Skin | No data available |
|
Dual Action Athlete's Foot cream
1310020Y0BGABAL
|
Boots Dual Action Athlete's Foot | Tolnaftate | Skin | No data available |
|
Dual Action Athlete's Foot powder
1310020Y0BGACAH
|
Boots Dual Action Athlete's Foot | Tolnaftate | Skin | No data available |
|
Dual Lax Extra Strong tablets
010602000BBBHA0
|
Proprietary compound preparation BNF 0106020 | Other stimulant laxative preparations | Gastro-Intestinal System | No data available |
|
Dubam cream
1003020N0BEACA0
|
Dubam | Methyl salicylate | Musculoskeletal and Joint Diseases | No data available |
|
Dubam spray
1003020N0BEABAM
|
Dubam | Methyl salicylate | Musculoskeletal and Joint Diseases | No data available |
|
Ducressa 1mg/ml / 5mg/ml eye drops
1104010I0BJAAAW
|
Ducressa | Dexamethasone | Eye | No data available |
|
Dulbalm cream
100302000BBBWA0
|
Proprietary compound preparation BNF 1003020 | Other rubefacient and topical antirheumatic preparations | Musculoskeletal and Joint Diseases | No data available |
|
Dulcobalance 10g oral powder sachets
0106040X0BCAAAA
|
Dulcobalance | Macrogol 4000 | Gastro-Intestinal System | No data available |
|
Dulcolax Pico 2.5mg Perles
0106020P0BDABAF
|
Dulcolax (Sodium picosulfate) | Sodium picosulfate | Gastro-Intestinal System | No data available |
|
Dumas Vault Cap No.1
21040000311
|
Dumas Vault Cap No.1 | Contraceptive Devices | Appliances | No data available |
|
Dumas Vault Cap No.2
21040000312
|
Dumas Vault Cap No.2 | Contraceptive Devices | Appliances | No data available |
|
Dumas Vault Cap No.3
21040000313
|
Dumas Vault Cap No.3 | Contraceptive Devices | Appliances | No data available |
|
Dumas Vault Cap No.4
21040000314
|
Dumas Vault Cap No.4 | Contraceptive Devices | Appliances | No data available |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.